Search Results - "Munschauer, FE III"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Interpreting patient/informant discrepancies of reported cognitive symptoms in MS by Carone, D A, Benedict, R H B, Munschauer, 3rd, F E, Fishman, I, Weinstock-Guttman, B

    “…Although numerous studies have shown that brain-damaged patients tend to underestimate neuropsychological (NP) impairment when self-ratings are compared to…”
    Get more information
    Journal Article
  2. 2

    Eight-year immunogenicity and safety of interferon beta-1a-Avonex registered treatment in patients with multiple sclerosis by Herndon, R M, Rudick, R A, Munschauer, FE III, Mass, M K, Salazar, A M, Coats, ME, Labutta, R, Richert, J R, Cohan, S L, Genain, C, Goodkin, D, Toal, M, Riester, K

    Published in Multiple sclerosis (01-08-2005)
    “…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFN beta -1a-Avonex) was conducted to evaluate the immunogenicity and…”
    Get full text
    Journal Article